Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
Peder Buchhave, Kaj Blennow, Henrik Zetterberg et al. · 2009
Read Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease by Peder Buchhave, Kaj Blennow, Henrik Zetterberg et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006294.txt.
Description
Two spinal fluid proteins can flag Alzheimer's disease even before symptoms show. Peder Buchhave, Kaj Blennow, and Henrik Zetterberg followed patients over time in a 2009 PLOS ONE study. Earlier reports on how tau and amyloid-beta-42 change within individuals disagreed with each other.
The longitudinal study tracked both markers in patients and elderly controls over repeated samples. Settling their time course is essential if the markers will guide diagnosis or trials. Stable markers can confirm disease; changing ones might track its progress. The paper clarifies what clinicians can expect from these tests.
Catalog record
| CREATOR | Peder Buchhave, Kaj Blennow, Henrik Zetterberg et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006294